APALUTAMIDE (has an active metabolite) | APALUTAMIDE | ATC L02BB05
ANTINEOPLASTIC ANDROGEN RECEPTOR INHIBITOR INDICATED FOR THE TREATMENT OF PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER | ORAL | Cmax 12.5 MICROMOLAR Tmax 3 HOUR F 100 PERCENT VD 276 LITER PPB 96 PERCENT Cl 1.3 LITER / HOUR HT 72 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN AQUEOUS MEDIA OVER A WIDE RANGE OF PH VALUES | ANDROGEN RECEPTOR | Androgen receptor UNIPROT P10275 AR more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |